TI
KZR

Trexquant Investment’s Kezar Life Sciences KZR Stock Holding History

Trexquant Investment’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,470
Closed -$46K – 1625
2023
Q1 		$46K Sell
1,470
-881
-37% -$51K ﹤0.01% 1393
2022
Q4 		$165K Sell
2,351
-4,322
-65% -$321K ﹤0.01% 1273
2022
Q3 		$575K Sell
6,673
-3,146
-32% -$306K 0.02% 754
2022
Q2 		$812K Buy
9,819
+6,233
+174% +$550K 0.04% 610
2022
Q1 		$596K Buy
3,586
+1,408
+65% +$202K 0.03% 689
2021
Q4 		$364K Buy
2,178
+564
+35% +$63.7K 0.02% 810
2021
Q3 		$139K Buy
1,614
+195
+14% +$12.9K 0.01% 1018
2021
Q2 		$77K Buy
+1,419
New +$80.6K 0.01% 1032
2020
Q3 		– Sell
-5,130
Closed -$266K – 1390
2020
Q2 		$266K Buy
+5,130
New +$259K 0.02% 938

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Trexquant Investment's KZR Position: Q2 2023 in Review

Trexquant Investment sold out of Kezar Life Sciences (KZR) in Q2 2023, closing a stake of 1,470 shares — an estimated $46K sold.

Trexquant Investment first reported a position in KZR in Q2 2020 and held it in 9 quarters. The position peaked at $812K in Q2 2022. 104 funds tracked by Wall St. Rank hold KZR as of Q2 2023.

  • Trexquant Investment reported no remaining Kezar Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Trexquant Investment sold 1,470 Kezar Life Sciences shares in Q2 2023, an estimated $46K.
  • Trexquant Investment first reported a position in Kezar Life Sciences in Q2 2020 and held it in 9 quarters.
  • Trexquant Investment's Kezar Life Sciences position peaked at $812K in Q2 2022.
  • 104 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2023.

Based on Trexquant Investment's 13F filing for Q2 2023, filed 11 Aug 2023.